Tag: ATHENA study
Anaconda Biomed secures US$56 million financing round
Anaconda Biomed today announced the closing of a US$56 million financing round with participation from new and existing investors. Proceeds will support product development...
Anaconda begins enrolment in ATHENA trial with first US patient treatment
Anaconda Biomed has announced the enrolment and treatment of the first US patient by Shahram Majidi (Mount Sinai, New York, USA) in its ATHENA...
Anaconda Biomed receives IDE approval to initiate enrolment in ATHENA study
Anaconda Biomed has announced that it has received conditional investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to begin...
